Aggressive angiomyxoma exhibits avid and heterogenous enhancement after administration of intravenous contrast and may show a distinct, low-intensity, swirling pattern (Figure 1).
Aggressive angiomyxoma of the female pelvis and perineum: report of nine cases of a distinctive type of gynecologic soft-tissue neoplasm.
1] CAF share pathological features of angiomyofibroblastoma and aggressive angiomyxoma (AAM), but do not fall into either category.
Angiomyofibroblastoma of the vulva; a benign neoplasm distinct from aggressive angiomyxoma.
In addition, aggressive angiomyxoma (AAM) of the female vulva has become established as a distinct clinical and pathologic entity.
Aggressive angiomyxoma and AMFB have been established as unusual angiomyxoid neoplasms of the female vulvovaginal tract that constitute distinct clinical and pathologic entities.
Clinical hypertrophy of the labia (vulvar), in which the histologic consideration is aggressive angiomyxoma (AA), has not been documented.
Aggressive angiomyxoma is a deep lesion, and the abnormalities should not be as superficial as those in our case.
Cellular angiofibroma can also be confused with aggressive vulvo-vaginal tumours like aggressive angiomyxoma
and solitary fibrous tumour (1, 5).
of the space of retzius: a case report.
There are 5 entities commonly accepted as myxomas: intramuscular myxoma, juxta articular myxoma, superficial angiomyxoma (or cutaneous myxoma), aggressive angiomyxoma
(usually pelvic and perineal regions) and myxoma of nerve sheath (myxoid neurothekeoma).
of pelvic parts exhibits estrogen and progesterone receptor positivity.